AMBARPIL · Ambar Protein Industries Limit · Financials
Market Cap
1.06B INR
Shares
5.75M
Volume · Nov 13
97
Avg daily vol (3M)
365
You came from your AI assistant. Add Equibles to it and ask about this data directly, free.
Income-statement, balance-sheet and cash-flow figures read from the company's own published financial reports.
Revenue
5.01B
+18.7%
FY2026
Net Income
70.27M
-27.2%
FY2026
Operating Cash Flow
29.61M
+36.3%
FY2026
Chart any reported metric, KPI or segment over time — the full statement history lives here
Search above to add metrics — fundamentals, product and segment revenue, company KPIs, valuation.
| Line Item | TTM | FY2026 | FY2025 |
|---|---|---|---|
| INR | 5.04B | 5.01B | 4.22B |
| INR | 14.05M | 13.67M | 13.11M |
| INR | 19.77M | 20.3M | 22.68M |
| INR | 136.6M | 93.86M | 130.31M |
| INR | 34.32M | 23.59M | 33.81M |
| INR | 102.28M | 70.27M | 96.5M |
Values reflect the latest filing (restatements included); per-share figures on today's split basis. Click a value for its source filing.
TTM: trailing twelve months through the latest reported quarter — flows sum the last four quarters, balances take the latest.
Capital Returned to Shareholders
Cash spent on share repurchases and dividends per fiscal year, as reported on the cash-flow statement. Across FY2025–FY2026: 0 in dividends.
Debt Profile
No verified debt profile is available yet. This does not establish that the company has no debt or covenants.